As if the several other fiscal challenges for the health care field were not more than enough, the COVID-19 pandemic is exacerbating speculative-grade issuer liquidity challenges, because of in portion to providers’ misplaced individual volumes as a end result of canceled elective surgical procedures, in accordance to a new report from Fitch Scores.
Specialty pharmaceutical firms with content financial debt maturities and opioid-contingent obligations are the most vulnerable. A number of significant-yield health care issuers have defaulted due to the fact the begin of the crisis, and near-expression credit score threat remains elevated deleveraging will rely on the speed of
